Literature DB >> 22022961

Glutamate receptor RNA editing in health and disease.

A Barbon1, S Barlati.   

Abstract

RNA editing is a post-transcriptional process with an important role in gene modification. This editing process involves site-selective deamination of adenosine into inosine in the pre-mRNA, leading to the alteration of translation codons and splicing sites in nuclear transcripts, thereby enabling functionally distinct proteins to arise from a single gene. One important instance is the neuron editing of the ionotropic glutamate receptors (iGluRs). GluRs play a key role in excitatory synaptic transmission and plasticity in the central nervous system (CNS); their channel properties are largely dictated by the subunit composition of the tetrameric receptors. AMPA/kainate channels are assembled from GluA1-4 AMPA or GluK1-5 kainate receptor subunits. In particular, three of the four AMPA and two of the five kainate receptor subunits are subject to RNA editing. The editing positions have been named on the basis of the amino acid substitutions, such as the Q/R site in AMPA GluA2; the Q/R site in GluK1 and GluK2; the R/G site in GluA2, GluA3, and GluA4; and the I/V and Y/C sites in GluK2. These amino acid changes lead to profound alterations of the channel properties. This paper reviews the most relevant data showing the importance of glutamate receptor RNA editing in finely tuning glutamatergic neurotransmission in the normal CNS and following alterations of the editing process in association with disease phenotypes. Overall, these data indicate that a highly regulated process of glutamate receptor editing is of key importance in the proper function of neuronal cells and in their ability to adapt and modulate synaptic function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22022961     DOI: 10.1134/S0006297911080037

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  15 in total

1.  Kainate receptor RNA editing is markedly altered by acute spinal cord injury.

Authors:  Luca Caracciolo; Fabio Fumagalli; Stephana Carelli; Laura Madaschi; Luca La Via; Daniela Bonini; Chiara Fiorentini; Sergio Barlati; Alfredo Gorio; Alessandro Barbon
Journal:  J Mol Neurosci       Date:  2013-08-27       Impact factor: 3.444

2.  Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.

Authors:  Daniela Bonini; Alice Filippini; Luca La Via; Chiara Fiorentini; Fabio Fumagalli; Marina Colombi; Alessandro Barbon
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.

Authors:  Eimile Oakes; Ashley Anderson; Aaron Cohen-Gadol; Heather A Hundley
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

4.  AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus.

Authors:  Isabella Russo; Daniela Bonini; Luca La Via; Sergio Barlati; Alessandro Barbon
Journal:  Neuromolecular Med       Date:  2013-03-15       Impact factor: 3.843

5.  Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing.

Authors:  Luca La Via; Daniela Bonini; Isabella Russo; Cesare Orlandi; Sergio Barlati; Alessandro Barbon
Journal:  Nucleic Acids Res       Date:  2012-11-19       Impact factor: 16.971

6.  A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.

Authors:  Mie Kubota-Sakashita; Kazuya Iwamoto; Miki Bundo; Tadafumi Kato
Journal:  Mol Brain       Date:  2014-01-21       Impact factor: 4.041

Review 7.  Channelopathy pathogenesis in autism spectrum disorders.

Authors:  Galina Schmunk; J Jay Gargus
Journal:  Front Genet       Date:  2013-11-05       Impact factor: 4.599

Review 8.  Adenosine-to-inosine RNA editing in neurological development and disease.

Authors:  Yuxi Yang; Shunpei Okada; Masayuki Sakurai
Journal:  RNA Biol       Date:  2021-01-06       Impact factor: 4.652

9.  Case-control study of ADARB1 and ADARB2 gene variants in migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Bridget Maher; Astrid J Rodriguez-Acevedo; Elhame Khlifi; Larisa M Haupt; Lyn R Griffiths
Journal:  J Headache Pain       Date:  2015-04-03       Impact factor: 7.277

10.  Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I.

Authors:  Valeska Lizzi Lagranha; Ursula Matte; Talita Giacomet de Carvalho; Bianca Seminotti; Carolina Coffi Pereira; David M Koeller; Michael Woontner; Stephen I Goodman; Diogo Onofre Gomes de Souza; Moacir Wajner
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.